Tharimmune, Inc. financial data

Symbol
THAR on Nasdaq
Location
Bridgewater, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 182% % -59%
Debt-to-equity 123% % 326%
Return On Equity -588% % -251%
Return On Assets -264% % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35,044,812 shares 2258%
Common Stock, Shares, Outstanding 7,207,341 shares 461%
Entity Public Float $1,700,000 USD -56%
Common Stock, Value, Issued $721 USD 459%
Weighted Average Number of Shares Outstanding, Basic 6,241,909 shares 303%
Weighted Average Number of Shares Outstanding, Diluted 6,241,909 shares 303%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $3,503,536 USD -34%
General and Administrative Expense $6,835,335 USD 17%
Operating Income (Loss) $10,338,871 USD 7%
Nonoperating Income (Expense) $19,626 USD -93%
Net Income (Loss) Attributable to Parent $10,319,245 USD 4.9%
Earnings Per Share, Basic -3 USD/shares 77%
Earnings Per Share, Diluted -3 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,610,340 USD 59%
Assets, Current $7,699,378 USD 47%
Assets $7,699,378 USD 47%
Accounts Payable, Current $659,254 USD -16%
Accrued Liabilities, Current $689,804 USD -50%
Liabilities, Current $1,544,551 USD -31%
Liabilities $1,544,551 USD -31%
Retained Earnings (Accumulated Deficit) $43,399,789 USD -31%
Stockholders' Equity Attributable to Parent $6,154,827 USD 104%
Liabilities and Equity $7,699,378 USD 47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,689,001 USD 4.8%
Net Cash Provided by (Used in) Financing Activities $205,568 USD -35%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 7,207,587 shares 461%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,483,433 USD 0.98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,610,340 USD 59%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,471 USD 80%
Deferred Tax Assets, Valuation Allowance $10,189,000 USD 53%
Deferred Tax Assets, Gross $10,189,000 USD 53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $49,623,860 USD 37%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $1,524,933 USD 128%
Interest Expense $15,067 USD -23%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%